PAVmed Inc. Series Z Warrant
PAVMZ
PAVMZ was delisted on the 30th of April, 2025.
6 hedge funds and large institutions have $38.8K invested in PAVmed Inc. Series Z Warrant in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.
14% less funds holding
Funds holding: 7 → 6 (-1)
45% less capital invested
Capital invested by funds: $70.4K → $38.8K (-$31.6K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$2.58K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$20.8K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$8.14K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$6.11K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$32 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RJA
1
Raymond James & Associates
St Petersburg,
Florida
| $27.9K | -$20.8K | -160,994 | -48% |
|
|
LCS
2
Levin Capital Strategies
New York
| $7.32K | – | – | – |
|
|
3
Citadel Advisors
Miami,
Florida
| $3.2K | +$2.58K | +19,982 | New |
|
4
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $160 | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $148 | -$32 | -245 | -21% |
|
6
Bank of America
Charlotte,
North Carolina
| $16 | – | – | – |
|
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$8.14K | -67,868 | Closed |
|
|
WAM
8
Wolverine Asset Management
Chicago,
Illinois
| – | -$6.11K | -40,757 | Closed |
|
PAVMZ Hedge Fund Activity: Q2 2023 in Review
6 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q2 2023, worth a combined $38.8K — down 45% from $70.4K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PAVMZ and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $2.58K. The largest seller was Raymond James & Associates, cutting an estimated $20.8K.
- 6 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q2 2023, down from 7 in Q1 2023.
- Funds reported $38.8K of PAVmed Inc. Series Z Warrant stock for Q2 2023, down 45% quarter-over-quarter.
- 1 fund opened new PAVmed Inc. Series Z Warrant positions in Q2 2023 and 2 closed out, a net change of -1 holder.
- The largest PAVmed Inc. Series Z Warrant buyer in Q2 2023 was Citadel Advisors, an estimated $2.58K added.
- The largest PAVmed Inc. Series Z Warrant seller in Q2 2023 was Raymond James & Associates, an estimated $20.8K sold.
Based on aggregated 13F filings for Q2 2023.